P27 JUMC

From LipidomicsWiki

Revision as of 07:55, 20 July 2011 by Richard Noragon (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search
InstitutionJagiellonian University Medical CollegeJagiellonian University Medical College
Principal investigator User:Aldona_Dembinska-Kiec

Email: Aldona Dembinska-Kiec

Telephone:+48 12-4214006 /+48 12-4218344
Country Poland
Beneficiary NumberP27
About usProf. Dembińska-Kieć, MD, PhD holder of the Alexander von Humboldt Scholarship

(Germany), trainings in England in the Research Department of Welcome Company with the group of Sir John Vane (the Nobel Prize 1983) and Prof. Salvador Moncada (prostanoids, nitric oxide and vessel wall). Vice-President of the Polish Angiological Society and Vice- President of Polish Atherosclerosis Society. In 1993-1997 she was the Vice-Rector of the JUMC. She managed 9 grants of the State Committee for Scientific Research of Poland (KBN). She was also a member of the scientific programs: INCO-COPERNICUS and POLONIUM, the EC COST-918 Action: Body Weight and Energy Expenditure, COST-B17 action: Insulin resistance, obesity and diabetes mellitus in the elderly. 2001-2003 coordination of the FW5 DLARFID “Dietary lipids as Risk Factors in Development. Mechanistic Issues QLK1-CT-2001-00183; Stem Cell Excellence Center QLK3-CT-2002- 30307 FW5 STEC. Member of Governing Board of NuGO: "The European Nutrigenomics Organisation linking genomics, nutrition and health research" (FP6-2004-506360). Participant of LIPGEN.“ Diet, genomics and the metabolic syndrome: an integrated nutrition, agro-food, social and economic analysis dietary fat modification, genotype and the metabolic syndrome (contract nr. FOOD-CT-2003-505944). SC&CR Stem Cell Products for Myocardial Repair" 502988. Mitfood (F&A0602, Bioactive food components, mitochondrial function and health)

COST (2007) action.
ContributionsThe Dembinska-Kiec lab brings access to patients with diabetes, metabolic syndrome and HIV. They have unique access to adipose tissue from HIV patients treated with protease inhibitors which generates lipodystrophy. They also can provide genetic and lipidomic analysis of such tissue.
Member of TaskforcesTask Force II, Task Force IV, Task Force VI, and Task Force IX
Member of WorkpackagesWP4 and WP8

Back to List of Beneficiaries

Personal tools
Create a book